Abstract Center

Session Format

• Location: Plenary Stage
• Length: 10 minutes
• Presentations:
  
  • Oral presentations of top-scoring abstracts
  • Short keynote(s) from invited experts
• Audience: All AANS Annual Scientific Meeting attendees
• Accreditation: Not CME-accredited

Submission Criteria

• Scientific Merit: Clear objectives, methods, results and conclusions
• Originality: New data or significant updates to existing work
• Clinical Relevance: Contributions that advance neurosurgical science or practice
• Balanced Perspective: Product references only when essential to describe methodology or results; comparative data encouraged

For Industry-Authored Abstracts

• No marketing or promotional language
• Company logos and product names may appear in titles or abstracts
• Full disclosure of funding and author affiliations required
• Industry presenters must pass the same blinded peer review as all other submitters

Review Process

• All submissions will undergo blinded peer review by highly qualified neurosurgeons
• Scoring based on scientific quality, originality, relevance and clarity
• Final selections reflect both top scores and topic balance
• Reviewers are chosen to avoid relevant financial relationships and preserve independence

Visit the 2026 Annual Meeting Submission Site and log in using your MyAANS username and password to submit an abstract.

• Abstract Title: An abstract must have a short, specific presentation title (containing no abbreviations) that indicates the nature of the presentation.  Titles should read as you want them to appear in meeting publications. Use title case capitalization, do not use all CAPITAL LETTERS and do not put a period at the end of the title. Example: This is a Properly Formatted Abstract Title  

• Presenting Author (Lead Author): Individual submitting the abstract.  

• • The Presenting Author is required to register and attend the meeting.  

• • The Presenting Author is expected to present (if applicable).  

• • • Note: e-Posters do not have an oral presentation requirement.    

• • The Presenting Author must submit under one’s own account.  

• • The Presenting Author’s account information/status (at the time of submission) is used to determine award eligibility.  

• • All correspondence with the Presenting Author is done via email.  

• Co-Authors: A co-author is an individual who helped you work on the abstract or someone that you would like to recognize in creation of the submission may be included as a co-author. List their full names with credentials and email addresses. All authors must be added to submissions before the deadline. Additional authors cannot be added to the submission after Saturday, October 18, 2025, 11:59 pm CT.   

• Disclosure: Disclosure is required for the presenting author, as well as agreement with the Terms and Conditions.  

• Topic Categories: APP, Cerebrovascular, Education, History, Pain, Pediatrics, Peripheral Nerve, Socioeconomic, Spine, Stereotactic and Functional, Trauma and Critical Care, Tumor.  

• Abstract Body: Include introduction, methods, results and conclusion sections. Text is limited to 320 words.  
• Additional Information: This includes elements such as previous presentation of the abstract, FDA approval, industry employment status, medical student/resident designation, senior author information, funding/database questions and award consideration. Review Work: You may review your abstract by selecting “Preview Abstract. “Proofread all abstracts before they are submitted to avoid errors. Once reviewed, hit the save submission button to confirm all tasks have been completed.    
• Submit: All tasks must be completed, and the abstract status must read “COMPLETE” on the submission site home screen for the abstract to be included in grading. Make sure to complete your abstract by hitting the submit button. A confirmation email will be sent.  

Note: Abstracts cannot contain advertising, trade names or product-group messaging. Include generic names or terms in your abstract content. If the abstract includes trade names, names from several companies should be used — not just trade names from a single company — to present all available treatment options. If trade names or company names are included in your abstract, the AANS reserves the right to remove them to ensure all scientific content is free from commercial bias.  

• Yes, you can make edits before the submission deadline. Once the review process begins, no changes to the submitted abstracts are allowed – no exceptions.   

• Please note that any typographical or spelling errors, improperly formatted titles, missing co-authors, etc., will not be edited by anyone at the AANS.  It is the responsibility of the submitter to review and verify all work submitted.   
• Please remember, after making any changes to your abstract, you must save and resubmit the abstract (even if it was previously submitted). The abstract status must read “COMPLETE” on the submission site home screen for the abstract to be included in grading. A confirmation email will be sent for every resubmission.  

• Oral Presentations: Top-ranked abstracts are selected for oral presentation during designated Plenary or Topical sessions. Presenters will deliver their research to a live audience within the scheduled session time.  

• Rapid Fire Oral Presentations: These concise presentations, lasting 2–3 minutes each, are scheduled within Plenary or Topical sessions. Abstracts are grouped by category, providing presenters the opportunity to highlight key findings in a fast-paced format.  

• Oral Paper Poster Presentations : This format features a 4’ x 6’ physical poster display of the abstract. Posters will be available for viewing in a designated area of the convention center. Each presenter will have up to 5 minutes to discuss their work during organized sessions, grouped into abstract categories.  
• e-Posters: E-Posters are one-page digital versions of accepted abstracts. They will be available for on-demand viewing throughout the Annual Meeting via the conference website, mobile app, and onsite kiosks. No formal presentation time is assigned for this format.

Previously presented or published material should not be submitted. It is acceptable if material has been submitted for publication but not actually published prior to the time it is scheduled to be presented at the AANS Annual Scientific Meeting.  

All abstract submitters will be notified by email in January 2026 of their abstract status.  

• Yes, all Presenting Authors are required to register and attend the 2026 AANS Annual Scientific Meeting in San Antonio, TX.  

• Registration must be completed Monday, February 16, 2026. If the presenting author does not complete registration by Monday, February 16, 2026, all accepted abstracts submitted by the presenting author will be declined.  

• No, the AANS does not allow for any charts, graphs or images in the abstract submission process.  

• Each submission is blindly reviewed by neurosurgeons whose specialty is within the category of submission. Last year, the committee of reviewers had more than 150 neurosurgeons participate in the review process.